Shree Gajanan Pharma & Surgical OPC Private Limited: Government Tender Analysis

Shree Gajanan Pharma & Surgical OPC Private Limited, a key player in the Indian pharmaceutical and surgical sector, actively participates in government tenders. This analysis provides a comprehensive overview of their tender performance, financial health, and competitive positioning, focusing on the period between April 2018 to March 2025. With a 3.1% win rate across 32 bids, Shree Gajanan Pharma is actively building its government procurement capabilities. The company has secured 1 L1 position to date.

From April 2018 to March 2025, Shree Gajanan Pharma bid on contracts totaling ₹86.62 lakh, demonstrating a focused approach to targeting and securing public sector projects. Their financial health score, assessed by TenderAI, stands at 35.4, indicating a 'Concerning' status. This score reflects factors like win rate, contract value, bid efficiency, and growth. The company's primary focus lies within the Rural Development and Panchayat Raj Department Maharashtra, showcasing specialized procurement expertise.

While Shree Gajanan Pharma has demonstrated a qualification rate of 68.8% in government tenders, opportunities exist to enhance technical compliance and improve the bid-to-win ratio. By addressing these areas, Shree Gajanan Pharma can strengthen its position in the competitive landscape and drive future growth in the Indian government procurement sector. The company's tender performance metrics highlight the need for a more selective bid strategy and improved bid preparation processes. Shree Gajanan Pharma can enhance its competitive approach and positioning in the public sector procurement landscape by improving in the government procurement capabilities.

Financial Performance Analysis

Yearly Trends

| Fiscal Year | Bid Count | Win Count | Qualification Rate | Win Rate | Total Contract Value |